Congestive Heart Failure: Major World Markets, Volume II: Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)

Best Price Guarantee	Publisher	Published Date	SKU
from $995	Kalorama Information	February, 2008	KLI1638430

Best Price Guarantee
Price	from $995
Publisher	Kalorama Information
Published Date	February, 2008
SKU	KLI1638430

Congestive heart failure, a condition caused by a malfunctioning heart that is unable to pump enough blood and oxygen to meet the body’s needs, is an increasingly important cause of cardiovascular morbidity and mortality. With improvements in the care of other cardiac conditions, more patients have developed dilated cardiomyopathy, which is the final common pathway for many cardiac illnesses and a common cause of congestive heart failure.

Kalorama Information's Congestive Heart Failure, Major World Markets series looks at markets for CHF treatment in the United States, Europe, Japan and the Rest of the World. Volume II of this series looks at markets for device management of this disease in the following key categories:

Pacemakers
Left Ventricular Assistance Devices (LVADs)
Implantable Cardioverter/Defibrillators (ICDs)
Artificial Hearts

The report offers revenue breakdowns the following world markets:

US
Europe
Japan
Rest of World

In addition to market forecasts and current market information, this report contains a thorough review of products available on the market and profiles of key companies, including:

Abbott Laboratories
Abiomed, Inc.
Ambu, USA
Aortech International, plc
Arrow International
Atrium Medical Corporation
ATS Medical, Inc.
Bacchus Vascular, Inc.
Berlin Heart AG
Biophan Technologies, Inc.
Biosensors International
Biotronik, Inc.
Boston Scientific
CardiacAssist, Inc.
Cardiac Science Corporation
Cardiogenesis Corporation
Cordis Corporation/Biologics Delivery Systems
CoreValve, Inc.
CryoCath Technologies, Inc.
Cryocor, Inc.
Datascope
Defibtech, LLC
Deltex Medical
Heartlab
Impulse Dynamics USA, Inc.
MedicalCV, Inc.
Medtronic, Inc.
Orqis Medical Corporation
Sorin SpA
Stereotaxis, Inc.
St. Jude Medical, Inc.
Teleflex Medical
Terumo Heart, Inc.
Thoratec Corporation
Ventracor, Inc.
Volcano Corporation

As part of Kalorama Information's methodology, analyst estimates are computed with intensive research of secondary data and literature, and primary research involving interviews of experts are used to test assumptions and validate models.

Product managers, business development executives, marketing executives and planners are among those who will benefit from this resource.

License Note: Kalorama Information's listed default price on its information products reflects a single user license only. Purchasing a departmental license (up to 10 users at one location) or a global site license (entire company) permits multiple individuals in the company to benefit from this resource.

Executive Summary
- BACKGROUND
- SCOPE AND METHODOLOGY
- SIZE AND GROWTH OF MARKET
  - Table The Estimated Markets for Devices Used to Treat CHF in the Major World Healthcare Markets by Geographic Segment ($ Millions)
Overview of Congestive Heart Failure
- BACKGROUND
  - Table International Cardiovascular Disease (CVD) Statistics (Rate per 100,000 Population)
  - Table United States CHF Statistics: 2004
- PATHOPHYSIOLOGY
  - Table CHF Data Sources
  - Types of Heart Failure
  - Conditions Leading to Congestive Heart Failure
    - Table Common Contributors to Congestive Heart Failure
  - Diagnosis of Congestive Heart Failure
  - Classification of Congestive Heart Failure Patients
- EPIDEMIOLOGY
  - Table Percentage Breakdown of Deaths from Cardiovascular Diseases: 2003
  - Table Incidence and Prevalence of CHF in the United States: 2007 - 2017 (Thousands)
  - Table The Distribution of Congestive Heart Failure In the Five Major European Healthcare Markets: 2007
  - Table Incidence and Prevalence of CHF in the Major Healthcare Markets of Europe: 2007 - 2017 (Thousands)
  - Table Incidence and Prevalence of CHF in Japan: 2007 - 2017 (Thousands)
Device Treatment of Congestive Heart Failure
- ARTIFICIAL PACEMAKERS
  - VENTRICULAR ASSIST DEVICES (VADS)
    - Table Key Implantable Heart Pacing Devices
  - TOTAL ARTIFICIAL HEARTS (TAHS)
    - Table Vascular Assist Devices
    - Table Total Artificial Heart Devices
    - Table Facilities Authorized to Performs Total Artificial Heart Implants
Congestive Heart Failure Patient Management
- GUIDELINES FOR MANAGEMENT OF CHRONIC HEART FAILURE
  - Table ACC/AHA Staging of Congestive Heart Failure
  - Table 2005 ACC/AHA Guidelines for Evaluation and Therapy for Congestive Heart Failure
- STRATEGIES TO MAINTAIN QUALITY PATIENT CARE AND CONTAIN COSTS
The Market for Therapeutic Devices in CHF
- Table The Estimated Markets for Devices Used to Treat CHF in the Major World Healthcare Markets by Geographic Segment ($ Millions)
- Table The Estimated Markets for Devices Used to Treat CHF in the Major World Healthcare Markets by Device Segment ($ Millions)
- Table The Estimated Markets for Devices Used to Treat CHF in the United States Healthcare Market by Device Segment (Pacemakers, ICDs, LVADs, and TAHs) ($ Millions)
- Table The Estimated Markets for Devices Used to Treat CHF in the Five Major European Healthcare Markets by Device Segment ($ Millions)
- Table The Estimated Markets for Devices Used to Treat CHF in the Japanese Healthcare Market by Device Segment ($ Millions)
Company Profiles
- ABBOTT LABORATORIES
- ABIOMED, INC.
- AMBU, USA
- AORTECH INTERNATIONAL, PLC
- ARROW INTERNATIONAL
- ATRIUM MEDICAL CORPORATION
- ATS MEDICAL, INC.
- BACCHUS VASCULAR, INC.
- BERLIN HEART AG
- BIOPHAN TECHNOLOGIES, INC.
- BIOSENSORS INTERNATIONAL
- BIOTRONIK, INC.
- BOSTON SCIENTIFIC
- CARDIACASSIST, INC.
- CARDIAC SCIENCE CORPORATION
- CARDIOGENESIS CORPORATION
- CORDIS CORPORATION/BIOLOGICS DELIVERY SYSTEMS
- CORE VALVE, INC.
- CRYOCATH TECHNOLOGIES, INC.
- CRYOCOR, INC.
- DATASCOPE
- DEFIBTECH, LLC
- DELTEX MEDICAL
- HEARTLAB
- IMPULSE DYNAMICS USA, INC.
- MEDICALCV, INC.
- MEDTRONIC, INC.
- ORQIS MEDICAL CORPORATION
- SORIN SPA
- STEREOTAXIS, INC.
- ST. JUDE MEDICAL, INC.
- TELEFLEX MEDICAL
- TERUMO HEART, INC.
- THORATEC CORPORATION
- VENTRACOR, INC.
- VOLCANO CORPORATION
Conclusions and Strategic Implications
- FIRST CONCLUSION
  - Implications:
- SECOND CONCLUSION
  - Implications:
- THIRD CONCLUSION
  - Implications:
- FOURTH CONCLUSION
  - Implications:
- FIFTH CONCLUSION
  - Implications:
- SIXTH CONCLUSION
  - Implications:
- SEVENTH CONCLUSION
  - Implications:
- EIGHTH CONCLUSION
  - Implications:
Glossary